[1]黄志斐 张秀兰.血浆载脂蛋白B与冠状动脉粥样硬化相关性研究进展[J].心血管病学进展,2021,(9):825-828.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
 HUANG ZhifeiZHANG Xiulan.The Correlation Between Plasma Apolipoprotein B and Coronary Atherosclerosis[J].Advances in Cardiovascular Diseases,2021,(9):825-828.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
点击复制

血浆载脂蛋白B与冠状动脉粥样硬化相关性研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年9期
页码:
825-828
栏目:
综述
出版日期:
2021-09-25

文章信息/Info

Title:
The Correlation Between Plasma Apolipoprotein B and Coronary Atherosclerosis
文章编号:
202103052
作者:
黄志斐1 张秀兰2
山西医科大学,山西 太原 030001;2.山西医科大学第二医院,山西 太原 030001)
Author(s):
HUANG Zhifei1ZHANG Xiulan2
Shanxi Medical University,Taiyuan 030001,Shanxi,China2. The Second Hospital of Shanxi Medical University,Taiyuan 030001,Shanxi,China)
Keywords:
Plasma apolipoprotein BAtherosclerosisCoronary atherosclerotic heart disease
DOI:
10.16806/j.cnki.issn.1004-3934.2021.09.000
Abstract:
Coronary atherosclerotic heart disease(CHD) is a common disease that threatens human life and health. Among them,dyslipidemia is the most important risk factor for CHD,which is closely related to the occurrence and development of coronary atherosclerosis. Plasma apolipoprotein B(ApoB) is one of the main components of plasma lipoprotein,which participates in the occurrence and development of atherosclerosis by mediating lipoprotein retention,inducing immune inflammation and cell apoptosis. Studies have shown that plasma ApoB is an important risk factor for CHD. In this paper,the molecular structure,metabolic pathway,atherogenic mechanism of plasma ApoB and clinical application of CHD are summarized as follows

备注/Memo

备注/Memo:

收稿日期:2021-03-10


更新日期/Last Update: 2021-10-21